Epigenome-Driven Strategies for Personalized Cancer Immunotherapy
Gabriel Iudy Yamaguchi Rocha,1 Jonathas Eduardo Miranda Gomes,1 Michel Lopes Leite,1,2 Nicolau B da Cunha,1,3,4 Fabricio F Costa1,5,6 1Genomic Sciences and Biotechnology Program, Catholic University of Brasilia, Brasília, DF, Brazil; 2Department of Cell Biology, Institute of Biological Sciences, Cam...
Main Authors: | Rocha GIY, Gomes JEM, Leite ML, da Cunha NB, Costa FF |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-12-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/epigenome-driven-strategies-for-personalized-cancer-immunotherapy-peer-reviewed-fulltext-article-CMAR |
Similar Items
-
Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses
by: Xi Chen, et al.
Published: (2020-05-01) -
Editorial: Genomics and Epigenomics of Cancer Immunotherapy: Challenges and Clinical Implications
by: Malak Abedalthagafi
Published: (2021-07-01) -
Personalized Cancer Immunotherapy: Today's Challenge and Tomorrow's Promise
by: Malaka Ameratunga, et al.
Published: (2018-10-01) -
EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma
by: Gang Xiao, et al.
Published: (2019-11-01) -
The follicular lymphoma epigenome regulates its microenvironment
by: Rada Amin, et al.
Published: (2022-01-01)